Main Article Content
Abstract
Vitiligo is a depigmentation disorder characterized by amelanotic skin patches, which may change shape and size with time, at times, leading to complete depigmentation of skin [1]. Hypopigmentation of the skin is attributed to the loss of epidermal melanocytes [2]. The disorder is associated with other co-morbidities like audiologic abnormalities [3] and lipid profile abnormalities [4]. There is a strong co-relation with autoimmune co-morbidities like psoriasis, thyroid disorders, rheumatoid arthritis, type I diabetes mellitus, alopecia areata, inflammatory bowel disease and systemic lupus [5]. The disease has socioeconomic implications